Maeda, H <br/><br/>
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.  [electronic resource] 

 -  Cancer research  Jul 2001 
 - 5432-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgens--physiology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Caspases--metabolism<br/>Cell Death--drug effects<br/>Cell Division--drug effects<br/>Dose-Response Relationship, Drug<br/>Enzyme Activation--drug effects<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases<br/>MAP Kinase Kinase 4<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, SCID<br/>Mitogen-Activated Protein Kinase Kinases--metabolism<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Neoplasm Metastasis--pathology<br/>Neoplasm Transplantation<br/>Neoplastic Stem Cells--drug effects<br/>Oxides--pharmacology<br/>Prostatic Neoplasms--drug therapy<br/>Reactive Oxygen Species--metabolism<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured<br/>Tumor Stem Cell Assay<br/>Xenograft Model Antitumor Assays<br/>p38 Mitogen-Activated Protein Kinases